Related Experiment Video

Updated: Jul 14, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

Mild Parkinsonian signs: An overview of an emerging concept

Elan D Louis1, David A Bennett

  • 1G.H. Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, New York, USA. EDL2@columbia.edu

Movement Disorders : Official Journal of the Movement Disorder Society
|May 31, 2007
PubMed

Insights

Mild Parkinsonian signs (MPS) are common in older adults and indicate increased risks for cognitive decline, dementia, and mortality. Identifying individuals with MPS can help predict future neurological diseases and guide interventions.

Area of Science:

  • Neurology
  • Geriatrics
  • Neuroscience

Background:

  • Mild Parkinsonian signs (MPS) are prevalent in older adults without diagnosed neurological conditions, affecting 15-95%.
  • These signs, including gait and balance issues, rigidity, bradykinesia, and tremor, are progressive and linked to functional decline.
  • MPS are associated with higher risks of mild cognitive impairment, dementia, and mortality.

Purpose of the Study:

  • To explore the unclear, multifactorial mechanistic basis of Mild Parkinsonian signs.
  • To identify individuals with MPS at higher risk for developing Alzheimer's disease, Parkinson's disease, or stroke.
  • To inform the development of therapeutic strategies to mitigate MPS-related morbidity and mortality.

Main Methods:

  • This study is a review and synthesis of existing research on Mild Parkinsonian signs.
  • Mechanistic hypotheses include age-associated dopaminergic decline, neurodegenerative pathologies (Lewy body, Alzheimer's type), and cerebrovascular pathology.
  • Focus is on identifying predictive markers and potential interventions.

Main Results:

  • The underlying causes of MPS are multifactorial and not fully understood.
  • Potential contributing factors include aging-related changes in the brain's dopamine system, early-stage neurodegenerative diseases, and vascular issues.
  • No specific results from a new study are presented, but the need for further research is highlighted.

Conclusions:

  • Understanding the mechanisms of MPS is crucial for early detection and intervention.
  • Identifying at-risk individuals can lead to personalized strategies to prevent or delay severe neurological outcomes.
  • Further research is needed to develop effective treatments for MPS and its associated risks.

Related Concept Videos

Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.